Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-22-006343

EVP, Corp Strategy & Develop sold 1,539 shares at an average $291.55 ($448,698)

  • EVP, Corp Strategy & Develop gave up 632 shares (to pay taxes)
  • EVP, Corp Strategy & Develop acquired 743 shares (option exercise)
  • EVP, Corp Strategy & Develop gave 150 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-14 Gift −150 21,675 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-18 Option exercise +743 $88.05 $65,421 22,418 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-18 Sale −1,143 $291.80 $333,527 21,275 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-22 Shares withheld for taxes −317 $293.61 $93,074 20,958 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-22 Sale −4 $290.81 $1,163 20,954 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-22 Sale −392 $290.83 $114,007 20,562 D
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-23 Shares withheld for taxes −315 $289.58 $91,218 20,247 D
Derivatives
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-18 Option exercise · Stock Options (Right to Buy) −743 0 D
Open-market sales · 1,539 sh · avg $291.55 · $448,698
Loading xslF345X03/form4.xml…